Asaf Danziger
2019
In 2019, Asaf Danziger earned a total compensation of $7.3M as Chief Executive Officer at NovoCure, a 60% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $693,139 |
|---|---|
| Option Awards | $4,472,183 |
| Salary | $702,295 |
| Stock Awards | $1,155,020 |
| Other | $293,970 |
| Total | $7,316,607 |
Danziger received $4.5M in option awards, accounting for 61% of the total pay in 2019.
Danziger also received $693.1K in non-equity incentive plan, $702.3K in salary, $1.2M in stock awards and $294K in other compensation.
Rankings
In 2019, Asaf Danziger's compensation ranked 1,276th out of 13,971 executives tracked by ExecPay. In other words, Danziger earned more than 90.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,276 out of 13,971 | 91st |
Division Manufacturing | 449 out of 5,701 | 92nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 57 out of 832 | 93rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 31 out of 535 | 94th |
Industry Surgical and Medical Instruments and Apparatus | 18 out of 350 | 95th |
Source: SEC filing on April 27, 2020.
Danziger's colleagues
We found four more compensation records of executives who worked with Asaf Danziger at NovoCure in 2019.